Patient reported outcomes in obstructive hypertrophic cardiomyopathy undergoing myectomy: Results from SPIRIT-HCM

Albree Tower-Rader1, Natalie Szpakowski2, Zoran B Popovic2

  • 1Hypertrophic Cardiomyopathy Center, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, United States of America; Department of Cardiovascular Medicine, Massachusetts General Hospital, Boston, MA, United States of America.

Insights

Surgical myectomy significantly improves quality of life in obstructive hypertrophic cardiomyopathy (oHCM) patients. While patient-reported outcomes (PROs) strongly correlate with each other, discordance with New York Heart Association (NYHA) class was noted.

Area of Science:

  • Cardiology
  • Patient-Reported Outcomes Research

Background:

  • Obstructive hypertrophic cardiomyopathy (oHCM) significantly impacts patient quality of life (QOL).
  • Patient-reported outcomes (PROs) are crucial for assessing QOL in oHCM.
  • Understanding the relationship between PROs, physician-reported metrics, and treatment outcomes is essential.

Purpose of the Study:

  • To investigate the correlation between various PROs in symptomatic oHCM patients.
  • To examine the association of PROs with the New York Heart Association (NYHA) functional class.
  • To evaluate the changes in PROs, functional capacity, and obstruction following surgical myectomy.

Main Methods:

  • A prospective study involving 173 symptomatic oHCM patients undergoing surgical myectomy.
  • PROs including KCCQ, PROMIS, DASI, and EQ-5D were collected at baseline and 12-month follow-up.
  • NYHA class, 6-minute walk test (6MWT), and peak left ventricular outflow tract gradient (PLVOTG) were also assessed.

Main Results:

  • Significant correlations were observed between different PROs (r-values 0.66-0.92, p<0.001).
  • Modest correlations were found between PROs and 6MWT/PLVOTG (r-values 0.2-0.5, p<0.01).
  • Surgical myectomy led to significant improvements in PROs, NYHA class, 6MWT distance, and PLVOTG at 12 months.

Conclusions:

  • Surgical myectomy effectively improves PROs, LVOT obstruction, and functional capacity in symptomatic oHCM patients.
  • A high degree of correlation exists among various PRO measures.
  • A notable discordance was observed between patient-reported outcomes and NYHA class.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
16
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14